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n 2006, Kidney International (KI) brought 
you a number of exciting changes to our 
appearance and content. We introduced a 
variety of articles beyond original research, 
from Journal Club and Commentaries to Edi-
torials and Reviews. Also introduced in 2006 
was a fresh, new design, which featured more 
colorful, artistic fi gures and images both on the 
cover and within the pages of each issue.
New: Editorial features
Now, in the fall of 2007, we are introducing new 
editorial features at every turn of the page. In 
this issue, you will fi nd some of our newest and 
most newsworthy content. An ongoing mini-
review series called ABC of Epidemiology (see 
page 411) will discuss the current challenges 
in designing and analyzing research results. 
ISN Forefronts in Nephrology (see page 397) 
highlights the important science discussed at 
past International Society of Nephrology (ISN) 
scientifi c meetings. Make Your Diagnosis (see 
page 521)  introduces a case, then leaves you 
guessing — at least until you fl ip the page for 
the answer — as to the diagnosis. In the August 
1 issue, you may remember reading another 
new feature, the Meeting Report (see page 247), 
which brings to light important issues in neph-
rology from recent meetings. More features to 
look out for in upcoming issues include Trans-
lational Nephrology, a series of three review 
articles published together that examine the 
basic, clinical, and physiological aspects of a 
condition; Book Review; and ISN Nexus, which 
will report on the latest ISN Nexus meetings.
New: Monthly podcasts
We are aware that you are busy and develop-
ing a growing interest in alternative online 
dissemination of services. To answer some of 
this need, we, together with Nature Publish-
ing Group, have launched a free monthly pod-
cast, bringing you highlights and interviews 
from the very best in research and practice. 
Our podcast is a 10- to 20-minute audio show 
you can listen to at your convenience. Listen 
by going to the KI web site http://www.nature.
com/ki/podcast or access it via iTunes, Win-
dows Media Player, RealPlayer, or QuickTime, 
and subscribe through services such as iTunes, 
Juice, or RSS readers.
New: Disclosure statement required
All biomedical journals face the serious issue of 
confl ict between the objectivity of authors and 
the requirement — appropriate, we think — of 
the pharmaceutical industry to demonstrate the 
utility of its drugs. Th e problem is that many, 
if not all, of the best clinical investigators are 
asked by the industry to examine their data 
and to provide help in the design or execu-
tion of research protocols. Th e use of the term 
‘confl ict of interest,’ we feel, is too suggestive of 
a confrontational approach, and one in which 
guilt seems to be implied. Th e term we there-
fore use to describe the relationship between 
authors and the pharmaceutical industry is ‘dis-
closure statement.’
Although we have always asked submitting 
authors to provide disclosure information, 
we now have a more stringent approach: we 
require all published authors of original work 
and reviews to fi ll out, sign, and return a legally 
binding disclosure statement, and to include 
a disclosure statement in the body of their 
papers. Our statement asks for the disclosure 
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of relationships in the form of consultation fees, paid advi-
sory board memberships, equity ownership/stock options, 
lecture fees, grant support, and patents and/or royalties. We 
are gratifi ed that you, our authors, are providing more explicit 
disclosure information now that the statement is required 
for publication. Th is non-prejudicial document of a purely 
informational kind allows our readers to conduct better analy-
sis of the published material.
You will fi nd more new editorial features, podcasts, and 
disclosure statements going forward as KI continues to 
evolve as an informative resource for everyone in the fi eld 
of nephrology.
